Replay available

DiaMedica Therapeutics Inc. (DMAC) Q4 2025 Earnings Call

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) Q4 2025 earnings conference call, held 2026-03-31. Replay captured from the company's public earnings webcast.

Tue, March 31, 2026 at 8:00 AMendedReplay
DiaMedica Therapeutics Inc. (DMAC) Q4 2025 Earnings Call

Hosted by

Featured presenters

Rick Pauls

President and Chief Executive Officer

Dr. Julie Kropp

Chief Medical Officer

Scott Kellan

Chief Financial Officer

Stacy Koo

Analyst, TD Cowen

Josh Shimmer

Analyst, Cantor

Thomas Flatton

Analyst, Lake Street

Matthew Caulfield

Analyst, HC Wainwright

Chase Knickerbocker

Analyst, Craig Hallam

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Diamedica Therapeutics Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.200 Good morning, ladies and gentlemen, and welcome to the Diomedica Therapeutics Full 00:00:05.200 -- 00:00:10.309 Year 2025 Earnings Conference Call. An audio recording 00:00:10.309 -- 00:00:15.959 of this webcast will be available shortly after the call today on Diomedica's 00:00:15.959 -- 00:00:19.722 website at www.diomedica.com. 00:00:22.053 -- 00:00:27.160 in the Investor Relations section. Before the company proceeds with its 00:00:27.160 -- 00:00:32.388 remarks, please note that the company will be making forward-looking statements 00:00:32.388 -- 00:00:38.096 on today's call. These statements are subject to risks and uncertainties 00:00:38.096 -- 00:00:43.684 that could cause the actual results to differ materially from those projected 00:00:43.684 -- 00:00:49.012 in these statements. More information including factors that could cause 00:00:49.012 -- 00:00:54.078 actual results to differ from projected results, appear in the section 00:00:54.078 -- 00:01:00.084 entitled Cautionary Statement Note Regarding Forward-Looking Statements 00:01:00.084 -- 00:01:05.250 in the company's press release issued yesterday and under the heading 00:01:05.250 -- 00:01:10.655 Risk Factors in Diamedica's most recent annual report 00:01:10.655 -- 00:01:12.838 on Form 10-K. 00:01:12.838 -- 00:01:19.244 Diamedica's SEC filings are available at www.sec.gov 00:01:22.130 -- 00:01:27.157 and on its website. Please also note that any comments 00:01:27.157 -- 00:01:32.344 made on today's call speak only as of today, March 31st, 00:01:32.344 -- 00:01:34.344 2026, 00:01:35.168 -- 00:01:40.715 and may no longer be accurate at the time of any rent replay or transcript 00:01:40.715 -- 00:01:46.463 rereading. Diomedica disclaims any duty to update its forward...